# OnCo record nct07659795 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07659795/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07659795", "NCT07659795" ;
  schema:name "A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer"@en ;
  schema:alternateName "TARGET-D 203"@en ;
  schema:description "A phase 2 trial of VS-7375, Cetuximab, Panitumumab in colorectal cancer, run by Verastem, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07659795/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07659795> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2026-07-28" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/vs-7375/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/folfox/> ;
  onco:companies <https://onco.cc/companies/verastem/> .